← FDA Drug Approvals (Drugs@FDA)

VIRAMUNE XR

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2011-03-25

Drug application

FDA Application #
NDA201152
Application type
New Drug Application
Brand name
VIRAMUNE XR
Generic name
Nevirapine
Active ingredients
NEVIRAPINE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing status
Discontinued
Sponsor
BOEHRINGER INGELHEIM
First approval
2011-03-25

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown